MedTrace Logo

THYME AND CARVACROLL Nanoparticle Effect on Fungi

NCT04431804 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2020-11-05

No results posted yet for this study

Summary

Invasive Aspergillosis (IA) has increasingly been recognized as an emerging disease of non-neutropenic patients and in patients admitted to the ICU, even in the absence of an apparent predisposing immune-deficiency, with incidence ranges from 0.3% to 5.8% with an overall mortality rate exceeding 80%.

Conditions

  • Aspergillosis

Interventions

OTHER

silver nanoparticle

fungicidal effect of silver nanoparticles on aspergillus isolates

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-11
Primary Completion
2020-09-20
Completion
2020-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04431804 on ClinicalTrials.gov